anthracene is converted by rat-liver homogenates into products with the properties of the 7-and 12-hydroxymethyl derivatives, the 7,12-dihydroxymethyl derivative, the related carboxylic acids and ring-hydroxylated products such as the 8,9-dihydro-8,9-dihydroxy derivative and phenols. Ring-hydroxylated products and products arising from the further oxidation of the hydroxymethyl groups were formed when the hydroxymethyl derivatives were themselves incubated with rat-liver homogenates. 2. Pretreatment of the animal with 3-methylcholanthrene or with Sudan III, which can protect rat adrenal glands from damage by 7,12-dimethylbenz[a]anthracene or by its 7-hydroxymethyl derivative, led to an increased rate of metabolism of 7,12-dimethylbenz[a]anthracene and its hydroxymethyl derivatives. The metabolic routes mainly affected were those involving the formation ofring-hydroxylated products. 3. Pretreatment with phenobarbitone led to a small increase in the rate ofmetabolism of the hydrocarbon and of its hydroxymethyl derivatives, but the increase appeared mainly to involve increased metabolism of the methyl and hydroxymethyl groups. 4. Pretreatment with metyrapone increased the rate of metabolism of the hydrocarbon mainly by increasing the amounts of products resulting from hydroxylation of the methyl groups: small increases in the amounts of ring-hydroxylated products were also produced. 8. Of a number of hydrocarbons and of derivatives of 3-methylcholanthrene tested as enzyme inducers, 3-methylcholanthrene itself was the most effective.
It was shown by Huggins & Morii (1961) that the treatment of rats with 7,12-dimethylbenz[a]anthracene (I) led to the destruction of two zones of the adrenal cortex and the induction of adrenal apoplexy. This effect could be inhibited by the administration before the hydrocarbon of any one of a number of compounds that are known to stimulate rat-liver microsomal enzymes (Huggins, Deuel & Fukunishi, 1963; Dao & Tanaka, 1963 (I) bitone (Huggins & Fukunishi, 1964; Huggins & Pataki, 1965) and metyrapone [2-methyl-1,2-bis-(3-pyridyl)propan-1-one] (Currie, Helfenstein & Young, 1962) . It was shown by Boyland, Sims & Huggins (1965) that 7-hydroxymethyl-12-methylbenz[a] anthracene, which is formed together with the isomeric 12-hydroxymethyl-7-methylbenz[a]-anthracene from the hydrocarbon in rat-liver homogenates (Boyland & Sims, 1965a) , is more effective than the hydrocarbon in inducing adrenal apoplexy in rats. The effect ofthe 7-hydroxymethyl derivative is also inhibited if the animals are pretreated with 3-methylcholanthrene (Professor C. Huggins, personal communication) . Rats with impaired liver function are protected against adrenal necrosis caused by 7,12-dimethylbenz[a]anthracene (Wheatley, Kernohan & Currie, 1966a) , whereas no protection is afforded against the action of the 7-hydroxymethyl derivative (WVheatley, Hamilton, Currie, Boyland & Sims, 1966b) . The action of the 7-hydroxymethyl derivative is, however, inhibited by pretreatment with metyrapone. These results suggested that the 7-hydroxymethyl 394 LIVER ENZYME INDUCTION AND ADRENAL NECROSIS derivative rather than the parent hydrocarbon was responsible for adrenal necrosis and that the effect of the pretreatments is to alter the metabolism of the hydrocarbon in the body so that the hydroxymethyl derivative either is not formed or is formed in decreased amounts or that it is further metabolized to inactive products. The metabolism of 7,12-dimethylbenz [a] anthracene and its hydroxymethyl derivatives in liver homogenates from normal rats and from rats that were pretreated with compounds that inhibit the formation of adrenal necrosis has therefore been examined. Conney & Levin (1966) found that the pretreatment of animals with any one of a number of compounds that are known to induce microsomal enzymes caused increases in the amounts of unidentified metabolites of 7,12-dimethylbenz [a] anthracene formed from the hydrocarbon by rat-liver homogenates, and Jellinck & Goudy (1966) 221, 232, 262, 272, 281-5, 290-5, 340, 355, 360 and 394m,t (loge 4-47, 4-30, 4-51, 4-53, 4-79, 4-87, 3-80, 3-88, 3-80 and 3-19 respectively). The methyl ester, prepared by the action of diazomethane in ether on the acid in methanol, was recrystallized from ethanol in pale-yellow needles, m.p. 1520 (Found: C, 84-5, H, 5-7. C21H1602 requires C, 84-0; H, 5-4%), A,,. at 221, 232, 262, 272, 281, 292, 340, 355, 360 and 394m,u (loge 4-45, 4-30, 4-51, 4-60, 4-83, 4-88, 3-83, 3-94, 3-83 and 3-18 polyhydroxy compouids and carboxylic acids. The zones were removed from the chromatograms, the corresponding zones from each set of chromatograms being combined, and the absorbed material was eluted from the silica gel with ether (lOOml.). The solutions were evaporated and the residues rechromatographed for 15cm. on single chromatograms. Usually the materials from the fastest-moving bands were chromatographed in solvent (a), the intermediate bands in solvent (b) and the material from the base lines in solvent (d). The chromatograms were examined in u.v.
light, and the u.v. spectra and in some cases the fluorescence spectra of the metabolites thus detected were measured as described above. The solutions were then evaporated and the residues either compared directly on thin-layer chromatograms with the appropriate synthetic compound or further examined as described below. No attempt was made at an exact determination of the amounts of the various metabolites formed in each incubation in these experiments. However, since the incubations were all carried out under standard conditions it was usually possible to compare, by a comparison of the heights of some of the peaks of the respective u.v. spectra, the amount of one particular metabolite formed by liver homogenate from normal rats with the amount of the same metabolite formed by the liver homogenatefrom treated animals.
Control experiments were carried out in which the homogenates were boiled before the addition of the cofactors and the substrates. Most of the metabolites described below were not detected under these conditions, but 7,12-dimethylbenz[a]anthracene sometimes yielded small amounts of the isomeric hydroxymethyl derivatives and the hydroxymethyl derivatives yielded small amounts of 7,12-dihydroxymethylbenz[a]anthracene. The amounts of these products formed were, however, much less than those formed when fresh homogenates were used.
All incubations yielded fast-moving fluorescent material which was also present in homogenates that were incubated without substrate. With 7,12-dimethylbenz[a]anthracene itself, the unmetabolized hydrocarbon was also present in this fluorescent material and both the monohydroxymethyl derivatives sometimes yielded unidentified products that moved to this region of the chromatograms.
(b) Quantitative experiments. In each experiment the livers of two rats, which had been pretreated with one of the compounds listed in Table 2 or 3, were pooled and homogenized, and the homogenate was centrifuged as before. The supernatant was divided into four equal portions, two of which were heated to 37°. The substrate (250ug.) in ethanol (0-5ml.) was added and the mixtures were immediately diluted with 2vol. of acetone. Nicotinamide (0-22g.) and the sodium salts of glucose 6-phosphate (31mg.) and NADP+ (4mg.) were added to each of the other portions and the mixtures were heated to 37°.
The substrate was added as before and the mixtures were incubated for 30min. and diluted with 2vol. of acetone. The four portions were extracted first with 150ml. and then with 50ml. of ethyl acetate, and the combined extracts were washed with water (150ml.) and dried over Na2SO4, and the solvent was evaporated. Each residue was applied to the base line of a thin-layer chromatogram that was developed for 15cm. with solvent (b). The regions of the chromatograms containing the hydrocarbon and the monohydroxymethyl derivatives were located by their fluorescence in u.v. light. The bands were removed and the absorbed material 396 1967 LIVER ENZYME INDUCTION AND ADRENAL NECROSIS was eluted from the silica gel by shaking with ethaanol (lOml.). The silica gel was removed by centrifugation and the eluted material was estimated by the fluorescence at 410m, when the activating wavelength was 360m,u. There was a straight-line relationship between concentration and intensity for concentrations up to 3,g./ml. so that where necessary the solutions were diluted. Recoveries of the substrates from the unincubated mixtures were about 70% of the amounts added; higher recoveries were possible if the mixtures were made strongly alkaline as described by Conney, Miller & Miller (1957) Table 1 ) and by its yellow colour on untreated chromatograms, was never detected as a metabolite of the hydrocarbon or of the related hydroxymethyl derivative. 12-Methylbenz[a]anthracene-7-carboxylic acid did not run on thin-layer chromatograms as a distinct spot, but when present it could usually be recognized by its distinctive u.v. spectrum when the material near the base lines of chromatograms developed in solvent (c) or (d) were examined. Confirmatory evidence was provided by treating the material from the base lines of these chromatograms with diazomethane in ether and examining the products on thin-layer chromatograms developed with solvent (b) for the presence of the methyl ester. The isomeric 7-methylbenz[a]-anthracene-12-carboxaldehyde and carboxylic acid were not prepared, but it was expected that their properties on thin-layer chromatograms would be similar to those of the corresponding 12-methyl derivatives. In a few experiments the incubated homogenates were acidified to pHl with concentrated hydrochloric acid before extraction with ethyl acetate: no increases in the amounts of the carboxylic acids recovered were detected.
The substance that appears to be the major metabolic product of 7,12-dimethylbenz[a]anthracene under the conditions used in this work behaves like a dihydrodihydroxy compound, since it yielded two phenols and small amounts of a number of other fluorescent products with acid when examined on two-dimensional thin-layer chromatograms. Of the phenols, the major product was that described by Boyland & Sims (1965a) , whereas the minor product (seen only when large amounts of the dihydrodihydroxy compound were chromatographed) formed a pink fluorescent spot when the chromatograms were examined in u.v. light in the presence of ammonia. These phenols were not chromatographically identical with those described above. The dihydrodihydroxy compound was tentatively identified as 8,9-dihydro-8,9-dihydroxy-7,12-dimethylbenz[a]anthracene (Boyland & Sims, 1965a) . It has been difficult to obtain further evidence for this structure, but a metabolic product of benz [a] t These products were also characterized by the acid-decomposition products formed on two-dimensional chromatograms as described in the text.
t These compounds were only obtained as metabolic products: the evidence for their structure is discussed in the text. § The isomeric 12-hydroxymethyl-7-methyl derivatives had identical properties.
established because it yielded 8-and 9-hydroxybenz[a]anthracene with acid (Boyland & Sims, 1964) . The fluorescence spectrum of the 7,12-dimethylbenz[a]anthracene metabolite (activation maximum at 330mu, fluorescence maximum at 390 and 410m,u) was similar to that of the unidentified metabolite A described by Conney & Levin (1966) (activation maximum at 320mu, fluorescence maximum at 388m,). The 7-and 12-hydroxymethyl derivatives similarly yielded products whose absorption and fluorescence spectra were similar to those of the hydrocarbon metabolite. These products are presumed to be 8,9-dihydro-8,9-dihydroxy -7-hydroxymethyl-12-methylbenz[a]anthracene (Am, , 269, 303, 316, 330, 358 and 373m, u and an inflexion at 284m,u) and 8,9-dihydro-8, The search in the reaction products for dihydrodihydroxy compounds formed on the 5,6-bonds (the 'K regions') of the hydrocarbon and the 7-hydroxymethyl derivative was carried out in two ways. First, attempts were made to find fluorescent bands in thin-layer chromatograms that had both the chromatographic properties and the characteristic u.v. spectra of the synthetic compounds. Secondly, with the hydrocarbon, the reaction products were examined on two-dimensional thin-layer chromatograsns for the phenol (presumably the 5-hydroxy compound) that should arise from the acid decomposition of the dihydrodihydroxy compound. No indication ofthe presence ofthe dihydrodihydroxy compounds was found in experiments 398 1967 LIVER ENZYME INDUCTION AND ADRENAL NECROSIS with homogenates from either treated or untreated animals, thus confirming earlier observations (Boyland & Sims, 1965a The results in Table 2 show that 7,12-dimethylbenz [a] anthracene is metabolized about four times as fast in liver homogenates from rats treated with 3-methylcholanthrene or with Sudan III as in homogenates from oil-treated controls. The largescale experiments showed that the metabolic route mainly affected was that yielding the compound believed to be 8,9-dihydro-8,9-dihydroxy-7,12-dimethylbenz [a] anthracene. The results of several experiments showed wide variation in the amounts of this compound formed, but increases of at least 300% and sometimes as much as 900% over the amounts formed in control experiments were always obtained. The reasons for these wide variations are not apparent. The results also showed that the amounts of the phenolic derivatives from homogenates of treated animals were larger than those from homogenates from the controls, as judged by a comparison of the intensities of the fluorescent bands on chromatograms of the respective products.
In contrast with the increases in the amounts of the ring-hydroxylated products described above, it is shown in Table 2 that the amounts of the monohydroxymethyl derivatives were much decreased as compared with the control when homogenates from animals treated either with 3-methylcholanthrene or with large amounts of Sudan III were used. In most large-scale experiments with animals treated with these inducers the amounts of the hydroxymethyl derivatives were much decreased and sometimes the derivatives were not detected in the reaction products. Occasionally, however, there appeared to be an increase rather than a decrease in the amount of the 7-(but not of the 12-) hydroxymethyl derivative: the reason for this is not known. 7,12-Dihydroxymethylbenz[a]anthracene was not detected as a metabolite in the homogenates from control animals, but was present in small amounts in those from treated animals.
The amounts of the carboxylic acids detected in the large-scale experiments were small, indicating that little of the added hydrocarbon was metabolized in this way. A comparison of the u.v. spectra of the metabolite from treated and control animals showed that twice as much was present in the homogenates from the treated than from the control animals. 8,9-Dihydro-8,9-dihydroxy-7-hydroxymethyl-12-methylbenz[a]anthracene and the isomeric 12-hydroxymethyl derivative could not be detected in the experiments with oil-treated animals, Table 2 . Effect of prsetreatment on the metaboli8m of 7,12-dimethylbenz[a]anthracene by rat-liver homogenate8
The compounds used for the pretreatments were administered in arachis oil (0-5ml.) as described in the text.
Unless otherwise indicated, the homogenates were incubated with the hydrocarbon as described in the text 40hr. liver/30min.)
Amount of derivative extracted from the homogenate derived from lg. of liver at the end of 30min. incubation
4-2+0-4 39+04
* A second dose was administered 20hr. before the homogenates were incubated.
t Four doses were given at 24, 20, 16 and 44hr. before the homogenates were incubated.
Vol. 104 399 E. BOYLAND AND P. SIMS but small amounts were present in the reaction products of experiments with animals treated with 3-methylcholanthrene and Sudan III. The largescale experiments also indicated that there were increases in the amounts of the phenols derived from the hydroxymethyl derivatives when homogenates from treated animals were used. These increases were difficult to measure because sharp u.v. spectra could not be obtained, but they appeared to be about fourfold. Pretreating rats with either phenobarbitone or with metyrapone increased the rates of metabolism of 7,12-dimethylbenz[a] anthracene and also increased slightly the yields of the monohydroxymethyl derivatives as compared with the corresponding values from control animals (see Table 2 ).
In the large-scale experiments small increases in the amounts of the dihydroxymethyl derivative and of the carboxylic acid as compared with the controls were detected with both compounds. There was no indication of any significant increases in the amounts of the other metabolites formed from animals pretreated with phenobarbitone, but small increases in the amounts of the 8,9-dihydro-8,9-dihydroxy compound in animals pretreated with metyrapone were detected: metyrapone was, however, less effective than 3-methyleholanthrene and Sudan III in the induction of the dihydrodihydroxy compound.
A few experiments were carried out in which rats were pretreated with 7,12-dimethylbenz[a]anthracene and benz [a] anthracene, both of which will protect rats against adrenal necrosis, although they are less effective than 3-methylcholanthrene (Huggins & Fukunishi, 1964) . The results in Table 2 show that both hydrocarbons cause increases in the amounts of 7,12-dimethylbenz[a]anthracene metabolized, and decreases in the amounts of the hydroxymethyl derivatives formed as compared with the controls, but that the effects are less than with 3-methylcholanthrene.
Several derivatives of 3-methylcholanthrene were also examined. 11,12-Epoxy-1 1,12-dihydro-3-methylcholanthrene was about half as effective as the parent hydrocarbon: the others were without effect (see Table 2 ).
Metabolism of 7-hydroxymethyl-12-methyl-and 12-hydroxymethyl -7-methyl-benz[a] anthracene. The results in Table 3 show that the hydroxymethyl derivatives were metabolized about four times as fast by homogenates from animals treated either with 3-methylcholanthrene or, for the 7-hydroxymethyl derivative, with large doses of Sudan III. Smaller doses of this inducer were less effective. The large-scale experiments showed that there were large increases in the amounts of the 8,9-dihydro-8,9-dihydroxy derivatives and smaller increases in the amounts of the phenolic derivatives formed from the hydroxymethyl compounds. There were also small increases in the amounts ofthe dihydroxymethyl derivative and of the carboxylic acids.
The results in Table 3 also show that the hydroxymethyl derivatives were metabolized faster in homogenates from animals treated with phenobarbitone than from those from controls. The large-scale experiments indicated that the increases were due to increases in the amounts of the dihydroxymethyl derivative and of the carboxylic acids: the amounts of the other derivatives were not affected.
Metabolism of 12-methylbenz[a]anthracene-7-carboxaldehyde. Qualitative examinations of the products from the incubations of the aldehyde with homogenates from control rats and from rats pretreated with 3-methylcholanthrene showed that both contained products resulting either from the and the monohydroxymethyl derivatives. The metabolic routes mainly affected appear to be those yielding 8,9-dihydro-8,9-dihydroxy compounds and phenols, but there are also small increases in products arising from the oxidation of methyl and hydroxymethyl groups. It is not clear from the experiments whether the decreases in the amounts of the hydroxymethyl derivatives are due to further oxidation of these derivatives or whether hydrocarbon that would normally be converted into the hydroxymethyl derivative is converted instead into the 8,9-dihydrodihydroxy derivative and the phenols. Although the incubations were carried out in the presence of large excesses of the hydrocarbon, presumably only small amounts of it are available for hydroxylation at any one moment because of its low solubility in the reaction medium. The 8,9-dihydro-8,9-dihydroxy derivatives are the major metabolic products of the hydroxymethyl compounds, but only relatively small amounts of the dihydrodihydroxy compounds were detected in the products of the incubations of the hydrocarbon with the homogenates from treated animals.
The pretreatment of rats with phenobarbitone, a compound that, when given repeatedly, acts as a protector against adrenal necrosis by 7,12-dimethylbenz [a] anthracene (the 7-hydroxymethyl derivative has not been-tested) (Huggins & Fukunishi, 1964) , did not have a profound effect on the metabolism of either the hydrocarbon or the 7-hydroxymethyl derivative by their liver homogenates. The small increases in the metabolic rate found appear to be due to increased hydroxylation of the methyl groups and the further oxidation of these products without any dramatic increases in ring-hydroxylated products. Presumably the conversion of the monohydroxymethyl derivative into 7,12-dihydroxymethylbenz [a] anthracene and into the carboxylic acid would have the same effect as ring hydroxylation in protecting the adrenal glands. The apparent differences in the metabolic routes stimulated by phenobarbitone and by 3-methylcholanthrene indicate that different enzymes are involved in ring and methyl group hydroxylation. In the metabolism of biphenyl, 4-hydroxylation is moderately stimulated by phenobarbitone and 2-hydroxylation is stimulated by 3-methylcholanthrene (Creaven & Parke, 1966) .
The pretreatment of rats with metyrapone increased the rate of metabolism of 7,12-dimethylbenz[a]anthracene by liver homogenates, apparently by stimulating the formation of the mono-and di-hydroxymethyl derivatives of the hydrocarbon, with only small alterations in the amounts of the ring-hydroxylated products formed. Currie, Helfenstein & Young (1962) and Dao & Tanaka (1963) showed that metyrapone will inhibit adrenal necrosis induced by 7,12-dimethylbenz[a]anthracene and Wheatley et al. (1966b) that it will inhibit adrenal necrosis induced by the 7-hydroxymethyl derivative. Metyrapone is an inhibitor of the 11l,-hydroxylation of steroids and therefore it decreases the concentrations of corticosterone and cortisol in the adrenal gland. It has been shown by Morii & Huggins (1962) that there is a correlation between damage to the adrenal gland by 7,12-dimethylbenz- [a] anthracene and high concentration of corticosterone in the gland. It is therefore possible that metyrapone acts in this way rather than as an enzyme stimulator. The experiments now described, together with those of Conney & Lewin (1966) and of Jellinck & Goudy (1966) , indicate that the pretreatment of
